Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program.
about
Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancerComparison of Circulating Tumour Cells and Circulating Cell-Free Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Undergoing Radiotherapy.Epstein-Barr virus and human papillomavirus infections and genotype distribution in head and neck cancersLengthening and shortening of plasma DNA in hepatocellular carcinoma patients.The impact of plasma Epstein-Barr virus DNA and fibrinogen on nasopharyngeal carcinoma prognosis: an observational studyPositivity of both plasma Epstein-Barr virus DNA and serum Epstein-Barr virus capsid specific immunoglobulin A is a better prognostic biomarker for nasopharyngeal carcinoma.Levels of plasma Epstein-Barr virus DNA prior and subsequent to treatment predicts the prognosis of nasopharyngeal carcinomaNon-invasive detection of nasopharyngeal carcinoma using saliva surface-enhanced Raman spectroscopy.IDH1 mutation detection by droplet digital PCR in glioma.The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseasesNasopharyngeal carcinoma incidence and mortality in China in 2009.Label-free blood plasma test based on surface-enhanced Raman scattering for tumor stages detection in nasopharyngeal cancer.Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinoma.iTRAQ-Based Quantitative Proteomic Analysis of Nasopharyngeal Carcinoma.Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting.Radiosensitization effect of nedaplatin on nasopharyngeal carcinoma cells in different status of Epstein-Barr virus infection.Liquid biopsies come of age: towards implementation of circulating tumour DNA.Integrating liquid biopsies into the management of cancer.Serum long non-coding RNAs MALAT1, AFAP1-AS1 and AL359062 as diagnostic and prognostic biomarkers for nasopharyngeal carcinoma.The Role of Epstein-Barr Virus DNA Load and Serology as Screening Tools for Nasopharyngeal Carcinoma.Real-time In vivo Diagnosis of Nasopharyngeal Carcinoma Using Rapid Fiber-Optic Raman Spectroscopy.Use of transoral nasopharyngeal brush biopsy for Epstein-Barr virus DNA detection of local recurrence of nasopharyngeal carcinoma after radiotherapy.Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancerSurvival outcome of patients with nasopharyngeal carcinoma: a nationwide analysis of 13 407 patients in Taiwan.Significant association between human osteosarcoma and simian virus 40.Evaluation of plasma Epstein-Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high-risk populations in Southern China.Serologic biomarkers of Epstein-Barr virus correlate with TNM classification according to the seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma.Cell-Free DNA Kinetics in a Pre-Clinical Model of Head and Neck Cancer.Incorporating Blood-based Liquid Biopsy Information into Cancer Staging: Time for a TNMB System?MR Imaging Criteria for the Detection of Nasopharyngeal Carcinoma: Discrimination of Early-Stage Primary Tumors from Benign Hyperplasia.Liquid Biopsy in Head and Neck Cancer: Promises and Challenges.Sequencing-based counting and size profiling of plasma Epstein-Barr virus DNA enhance population screening of nasopharyngeal carcinoma.The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma.Assessment of the Long-term Diagnostic Performance of a New Serological Screening Scheme in Large-scale Nasopharyngeal Carcinoma Screening.Epstein–Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update.Epstein-Barr virus and nasopharyngeal carcinoma
P2860
Q26746010-B3EDDA16-BA5C-46BA-AC60-CEC2BE849692Q33685029-D3575156-24EE-4179-A031-93473D0FE3AFQ34535924-D3D029AB-A7F2-4FD0-ADBD-4557BC3CE33CQ35212779-BFAA81AA-AF0A-44F6-8FD8-D43FC952D6E7Q35678382-EAD93E25-17AD-4F45-9412-769235986262Q36305182-87C49FB0-8039-472A-B7E7-8106BBA5A9FEQ36335515-08360451-EBF3-450A-922B-D7D87F7253DDQ36502753-0F2F5567-FA8E-43A1-8758-8472FBECF241Q36545444-5703E3E7-61D9-4CCD-A14F-2A138F00A5B3Q36825808-1F046707-9A2E-4A76-9F34-16E7A025D8EEQ37354037-4CA2137E-3899-422F-9EA3-DE41325C376BQ37718102-3F03059D-C0D0-4F81-B628-A6B72F35E691Q38270678-0A488ADF-7B55-4502-B2E2-3744F89521A5Q38913291-FB72003D-1194-4F9E-88CE-6CDB12BE6294Q38959017-77FDEAD1-A7BB-4420-8C35-174CA873719BQ38988048-47B32AA0-91F7-4E1C-9D4A-3C9681C0DDE6Q39149201-AF491D12-8E46-43C3-806A-96222A3F4332Q39157824-80042F1B-F957-4A0C-93D8-862D2B22A54EQ40228185-58E575BF-869D-4C63-8D6A-9F97FB7E4900Q40770021-DD0B442F-5CAC-4595-874D-A7B528B99103Q41173985-B252EA14-A0A3-4FAD-9152-078CD559CB57Q41333975-F8E46EBF-A377-4FC7-A14B-4AF253EF4699Q41547611-D57975A6-EA61-4C8F-B7CF-AB80DE27C495Q41592585-5D9742E6-D7A8-41F6-8531-755549C7C649Q42181980-D8943ABB-B6C6-4CF9-8959-1CFE517DED07Q42240169-1E86DF0C-D6E4-4B63-99FF-CB0F43DF6B35Q42256571-27A2DA55-1F0F-44DC-BF2B-D8486996C22AQ47136367-D69A0506-96FB-4511-B8CB-C1F8FF20D7D5Q47563363-2506F3E6-3659-4188-8470-71A0A27898F0Q48334944-18D93DE5-E191-4B34-83FC-600BBBC4039AQ52669514-8B633ACF-B07E-4301-9812-A8AFBF861864Q54212216-B6AC8518-58B4-4F4B-89CD-209856722762Q54254993-634A6C5E-EE09-47A7-826D-F755C8E52DF6Q55280881-674C97B2-D6B5-4BEB-922B-5E6D01351FEFQ55312268-F981BB00-9CCC-42CD-95B6-13639C9E58D7Q56947843-CAB361FA-4F26-4CF7-BBE5-BCE927F60983
P2860
Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Early detection of nasopharyng ...... sis in a surveillance program.
@en
Early detection of nasopharyng ...... sis in a surveillance program.
@nl
type
label
Early detection of nasopharyng ...... sis in a surveillance program.
@en
Early detection of nasopharyng ...... sis in a surveillance program.
@nl
prefLabel
Early detection of nasopharyng ...... sis in a surveillance program.
@en
Early detection of nasopharyng ...... sis in a surveillance program.
@nl
P2093
P2860
P356
P1433
P1476
Early detection of nasopharyng ...... sis in a surveillance program.
@en
P2093
Andrew C van Hasselt
Anita S M Cheng
Ann D King
Anthony T C Chan
Emily C W Hung
Franco P T Lai
Jeffrey S S Kwok
John K S Woo
K C Allen Chan
Paul K S Chan
P2860
P304
P356
10.1002/CNCR.28001
P407
P577
2013-02-21T00:00:00Z